|
|
|
|
Does heartburn lead to cancer?
DEAR DR.DONOHUE: I was diagnosed a year ago with Barrett's esophagus with no dysplasia. I tried taking a generic version of Nexium, but it did not help at all. A second doctor advised me not to take drugs, since they didn't help. I tried more...
|
|
|
Aging Committee raps pharma on brand drug price hikes
Armed with AARP and Kaiser Family research, members of the Senate Special Committee on Aging asked panelists why brand drug prices in the US continue to increase, while other countries pay half as much for the same products.The hearing, led by guest chair Sen....
|
|
|
AHRQ pump clots
BC-AHRQ-pump-clots To: NATIONAL EDITORS Contact: AHRQ Public Affairs, +1-301-427-1539, or +1-301-427-1998 ROCKVILLE, Md., March 15 /PRNewswire-USNewswire/ -- Heart patients who took a stomach acid-suppressing proton-pump inhibitor along with clopidogrel - a...
|
|
|
Reflux surgery tops pills in the short term
Last Updated: 2010-03-17 13:00:25 -0400 (Reuters Health) By Megan Brooks NEW YORK (Reuters Health) - People who suffer from chronic severe stomach acid reflux have two options -- long-term medication or anti-reflux surgery.A new review of the medical...
|
|
|
UPDATE:Sen Kohl Probes Price Differences In Drugs In US, Abroad
Of DOW JONES NEWSWIRES WASHINGTON -(Dow Jones)- Sen.Herb Kohl (D., Wisc.) is pressing pharmaceutical companies such as GlaxoSmithKline PLC (GSK, GSK.LN), Eli Lilly & Co. (LLY) and Pfizer Inc. (PFE) to explain why their drugs often cost four times...
|
|
|
UPDATE:Sen Kohl Probes Price Differences In Drugs In US, Abroad
WASHINGTON -(Dow Jones)- Sen.Herb Kohl (D., Wisc.) is pressing pharmaceutical companies such as GlaxoSmithKline PLC (GSK, GSK.LN), Eli Lilly & Co. (LLY) and Pfizer Inc. (PFE) to explain why their drugs often cost four times more in the U.S.
|
|
|
Sen Kohl Probes Price Differences In Drugs Sold In US, Abroad
WASHINGTON -(Dow Jones)- Sen.Herb Kohl (D., Wisc.) is pressing pharmaceutical companies such as GlaxoSmithKline PLC (GSK, GSK.LN), Eli Lilly & Co. (LLY) and Pfizer Inc. (PFE) to explain why their drugs often cost four times more in the U.S.
|
|
|
Biogel adds two new surgical gloves with improved grip to non-latex polyisoprene line
Patients who take a proton-pump inhibitor with medicine to prevent blood clots are less likely to be hospitalized for bleeding ulcers Heart patients who took a stomach acid-suppressing proton-pump inhibitor along with clopidogrela drug that prevents blood...
|
|
|
GHX launches Procurement Suite spend management solution for hospitals
Patients who take a proton-pump inhibitor with medicine to prevent blood clots are less likely to be hospitalized for bleeding ulcers Heart patients who took a stomach acid-suppressing proton-pump inhibitor along with clopidogrela drug that prevents blood...
|
|
|
Cancer costs more than doubled in 40-year fight
Patients who take a proton-pump inhibitor with medicine to prevent blood clots are less likely to be hospitalized for bleeding ulcers Heart patients who took a stomach acid-suppressing proton-pump inhibitor along with clopidogrela drug that prevents blood...
|
|
|
Atul Gawande, MD, speaks out for checklists in the OR at AORN
Patients who take a proton-pump inhibitor with medicine to prevent blood clots are less likely to be hospitalized for bleeding ulcers Heart patients who took a stomach acid-suppressing proton-pump inhibitor along with clopidogrela drug that prevents blood...
|
|
|
Patients who take a proton-pump inhibitor with medicine to prevent blood clots are less likely to be hospitalized for bleeding ulcers
Heart patients who took a stomach acid-suppressing proton-pump inhibitor along with clopidogrela drug that prevents blood clotswere only half as likely to be hospitalized for upper digestive tract bleeding than those who used clopidogrel alone, according to a...
|
|
|
Forensic role of bacteria?
Patients who take a proton-pump inhibitor with medicine to prevent blood clots are less likely to be hospitalized for bleeding ulcers Heart patients who took a stomach acid-suppressing proton-pump inhibitor along with clopidogrela drug that prevents blood...
|
|
|
Proton-Pump Inhibitor Plus Clopidogrel Is Less Likely To Cause Bleeding Ulcers
Heart patients who took a stomach acid-suppressing proton-pump inhibitor along with clopidogrel a drug that prevents blood clots were only half as likely to be hospitalized for upper digestive tract bleeding than those who used clopidogrel alone, according to a...
|
|
|
Sen Kohl Probes Price Differences In Drugs Sold In US, Abroad
WASHINGTON -(Dow Jones)- Sen.Herb Kohl (D., Wisc.) is pressing pharmaceutical companies such as GlaxoSmithKline PLC (GSK, GSK.LN), Eli Lilly & Co. (LLY) and Pfizer Inc. (PFE) to explain why their drugs often cost four times more in the U.S.
|
|
|
Concurrent use of proton-pump inhibitor and clopidogrel does not elevate cardiovascular risk
Heart patients who took a stomach acid-suppressing proton-pump inhibitor along with clopidogrel - a drug that prevents blood clots - were only half as likely to be hospitalized for upper digestive tract bleeding than those who used clopidogrel alone, according...
|
|
|
Proton-Pump Inhibitor Plus Clopidogrel Is Less Likely to Cause Bleeding Ulcers
Source: Agency for Healthcare Research and Quality (AHRQ) Newswise Heart patients who took a stomach acid-suppressing proton-pump inhibitor along with clopidogrel a drug that prevents blood clots were only half as likely to be hospitalized for upper digestive...
|
|
|
Crestor, Plavix make new Chinese formulary
China is a promising new market for Big Pharma.And when its government makes a healthcare-related move, the news reverberates throughout the drug industry. Today, it's a good reverberation: China's National Reimbursement Drug List is being updated for the...
|
|
|
China Drug List Seen Boosting Western Firms' Sales
Chinese plans to broaden the list of medicines eligible for a rebate from July will benefit Western drugmakers such as AstraZeneca and Sanofi-Aventis, according to Morgan Stanley analysts.The National Reimbursement Drug List is being updated for the first...
|
|
|
China drug list seen boosting Western firms' sales
LONDON (Reuters) - Chinese plans to broaden the list of medicines eligible for a rebate from July will benefit Western drugmakers such as AstraZeneca and Sanofi-Aventis, according to Morgan Stanley analysts.The National Reimbursement Drug List is being...
|
|
|
China drug list seen boosting Western firms' sales
Tools and articles to help you manage your finances better The National Reimbursement Drug List is being updated for the first time since 2004 with many Western drugs added to the category that entitles patients to a rebate of up to 50 percent.New entrants...
|
|
|
China drug list seen boosting Western firms' sales
LONDON (Reuters) - Chinese plans to broaden the list of medicines eligible for a rebate from July will benefit Western drugmakers such as AstraZeneca and Sanofi-Aventis, according to Morgan Stanley analysts.The National Reimbursement Drug List is being...
|
|
|
China drug list seen boosting Western firms' sales
43 mins ago LONDON (Reuters) Chinese plans to broaden the list of medicines eligible for a rebate from July will benefit Western drugmakers such as AstraZeneca and Sanofi-Aventis, according to Morgan Stanley analysts.The National Reimbursement Drug List is...
|
|
|
China drug list seen boosting Western firms' sales
LONDON, March 15 (Reuters) - Chinese plans to broaden the list of medicines eligible for a rebate from July will benefit Western drugmakers such as AstraZeneca and Sanofi-Aventis, according to Morgan Stanley analysts.The National Reimbursement Drug List is...
|
|
|
China drug list seen boosting Western firms' sales
LONDON, March 15 (Reuters) - Chinese plans to broaden the list of medicines eligible for a rebate from July will benefit Western drugmakers such as AstraZeneca and Sanofi-Aventis, according to Morgan Stanley analysts.The National Reimbursement Drug List is...
|
